# Ologen (OculusGen)-Glaucoma Case Control Trial in India

> **NCT00448929** · PHASE3 · COMPLETED · sponsor: **Pro Top & Mediking Company Limited** · enrollment: 40 (actual)

## Conditions studied

- Glaucoma

## Interventions

- **DEVICE:** OculusGen Biodegradable Collagen Matrix Implant

## Key facts

- **NCT ID:** NCT00448929
- **Lead sponsor:** Pro Top & Mediking Company Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2017-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00448929

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00448929, "Ologen (OculusGen)-Glaucoma Case Control Trial in India". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00448929. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*